Jeff Yass’s DNA X Inc SONM Stock Holding History

Jeff Yass’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,520	Closed	-$16.5K	–	13532
2025 Q3	$16.5K	Buy	+1,520	New	+$17.6K	﹤0.01%	12069
2025 Q2	–	Sell	-860	Closed	-$33.1K	–	13644
2025 Q1	$33.1K	Buy	+860	New	+$41K	﹤0.01%	11984
2022 Q4	–	Sell	-77	Closed	-$7K	–	13590
2022 Q3	$7K	Sell	77 -613	-89%	-$76.1K	﹤0.01%	12840
2022 Q2	$68K	Buy	690 +413	+149%	+$46.6K	﹤0.01%	11788
2022 Q1	$43K	Buy	277 +113	+69%	+$15.3K	﹤0.01%	12375
2021 Q4	$27K	Buy	+164	New	+$49.8K	﹤0.01%	12764

Other funds holding SONM

PCM

Potomac Capital Management New York $147M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Jeff Yass's SONM Position: Q4 2025 in Review

Jeff Yass sold out of DNA X Inc (SONM) in Q4 2025, closing a stake of 1,520 shares — an estimated $16.5K sold.

Jeff Yass first reported a position in SONM in Q4 2021 and held it in 6 quarters. The position peaked at $68K in Q2 2022. 8 funds tracked by Wall St. Rank hold SONM as of Q4 2025.

Jeff Yass reported no remaining DNA X Inc position as of Q4 2025 after selling out during the quarter.
Jeff Yass sold 1,520 DNA X Inc shares in Q4 2025, an estimated $16.5K.
Jeff Yass first reported a position in DNA X Inc in Q4 2021 and held it in 6 quarters.
Jeff Yass's DNA X Inc position peaked at $68K in Q2 2022.
8 funds tracked by Wall St. Rank held DNA X Inc as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.